{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:38:49Z","timestamp":1789605529918,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07897-1","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T22:57:48Z","timestamp":1736290668000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis"],"prefix":"10.1007","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1805-3181","authenticated-orcid":false,"given":"Vittorio","family":"Unfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3610-2145","authenticated-orcid":false,"given":"Elisa","family":"Lepore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4720-4054","authenticated-orcid":false,"given":"Gianpiero","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imela","family":"Hern\u00e1ndez Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7011-2345","authenticated-orcid":false,"given":"Artur","family":"Wdowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4690-9140","authenticated-orcid":false,"given":"Lali","family":"Pkhaladze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"7897_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fendo.2019.00388","volume":"10","author":"G Papadakis","year":"2019","unstructured":"Papadakis G, Kandaraki EA, Tseniklidi E, Papalou O, Diamanti-Kandarakis E (2019) Polycystic ovary syndrome and nc-cah: distinct characteristics and common findings. A systematic review. Front Endocrinol (Lausanne) 10:388","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"7897_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1210\/jc.2007-2053","volume":"93","author":"HF Escobar-Morreale","year":"2008","unstructured":"Escobar-Morreale HF, Sanchon R, San Millan JL (2008) A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 93(2):527\u2013533","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"7897_CR3","first-page":"307","volume":"10","author":"D Chanukvadze","year":"2012","unstructured":"Chanukvadze D, Kristesashvili J, Kvashilava N (2012) Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH). Iran J Reprod Med 10(4):307\u2013314","journal-title":"Iran J Reprod Med"},{"issue":"9","key":"7897_CR4","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.3390\/diagnostics12092045","volume":"12","author":"M Yesiladali","year":"2022","unstructured":"Yesiladali M, Yazici MGK, Attar E, Kelestimur F (2022) Differentiating polycystic ovary syndrome from adrenal disorders. Diagnostics (Basel) 12(9):2045","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"7897_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1055\/s-2007-984741","volume":"25","author":"SK Blank","year":"2007","unstructured":"Blank SK, McCartney CR, Helm KD, Marshall JC (2007) Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med 25(5):352\u2013359","journal-title":"Semin Reprod Med"},{"issue":"2","key":"7897_CR6","doi-asserted-by":"publisher","first-page":"e3000002","DOI":"10.1371\/journal.pbio.3000002","volume":"17","author":"PJ O'Shaughnessy","year":"2019","unstructured":"O\u2019Shaughnessy PJ, Antignac JP, Le Bizec B, Morvan ML, Svechnikov K, S\u00f6der O et al (2019) Alternative (backdoor) androgen production and masculinization in the human fetus. PLoS Biol 17(2):e3000002","journal-title":"PLoS Biol"},{"issue":"18","key":"7897_CR7","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.3390\/ijms20184605","volume":"20","author":"F Baronio","year":"2019","unstructured":"Baronio F, Ortolano R, Menab\u00f2 S, Cassio A, Baldazzi L, Di Natale V et al (2019) 46, XX DSD due to androgen excess in monogenic disorders of steroidogenesis: genetic, biochemical, and clinical features. Int J Mol Sci 20(18):4605","journal-title":"Int J Mol Sci"},{"issue":"5","key":"7897_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.4239\/wjd.v12.i5.616","volume":"12","author":"K Unluhizarci","year":"2021","unstructured":"Unluhizarci K, Karaca Z, Kelestimur F (2021) Role of insulin and insulin resistance in androgen excess disorders. World J Diabetes 12(5):616\u2013629","journal-title":"World J Diabetes"},{"issue":"10","key":"7897_CR9","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s40618-020-01235-3","volume":"43","author":"C Oriolo","year":"2020","unstructured":"Oriolo C, Fanelli F, Castelli S, Mezzullo M, Altieri P, Corzani F et al (2020) Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone. J Endocrinol Invest 43(10):1499\u20131509","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"7897_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/cen.14710","volume":"97","author":"L Cussen","year":"2022","unstructured":"Cussen L, McDonnell T, Bennett G, Thompson CJ, Sherlock M, O\u2019Reilly MW (2022) Approach to androgen excess in women: clinical and biochemical insights. Clin Endocrinol (Oxf) 97(2):174\u2013186","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7897_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14802","author":"FIL de Zegher","year":"2024","unstructured":"de Zegher FIL (2024) Leader vs follower in the tango of polycystic ovary syndrome: insulin resistance vs androgen excess. Acta Obstet Gynecol Scand. https:\/\/doi.org\/10.1111\/aogs.14802","journal-title":"Acta Obstet Gynecol Scand"},{"key":"7897_CR12","first-page":"1","volume":"26","author":"M Calcagno","year":"2024","unstructured":"Calcagno M, Serra P, Etrusco A, Margioula-Siarkou C, Terzic S, Giannini A et al (2024) A bitter pill to swallow: adjustments to oral contraceptive pill use in polycystic ovary syndrome. Expert Opin Pharmacother 26:1\u20137","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"7897_CR13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.tem.2023.08.005","volume":"34","author":"SH Myers","year":"2023","unstructured":"Myers SH, Russo M, Dinicola S, Forte G, Unfer V (2023) Questioning PCOS phenotypes for reclassification and tailored therapy. Trends Endocrinol Metab 34(11):694\u2013703","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"7897_CR14","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00404-024-07408-2","volume":"309","author":"SH Myers","year":"2024","unstructured":"Myers SH, Montanino Oliva M, Nordio M, Unfer V (2024) PCOS phenotype focus: phenotype D under the magnifying glass. Arch Gynecol Obstet 309(6):2307\u20132313","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"7897_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/17446651.2019.1576522","volume":"14","author":"DH Abbott","year":"2019","unstructured":"Abbott DH, Dumesic DA, Levine JE (2019) Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy. Expert Rev Endocrinol Metab 14(2):131\u2013143","journal-title":"Expert Rev Endocrinol Metab"},{"key":"7897_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1017\/9781108989831.008","volume-title":"Adrenal and polycystic ovary syndrome","author":"O Celik","year":"2022","unstructured":"Celik O, Yildiz BO (2022) Adrenal and polycystic ovary syndrome. Cambridge University Press, p 67"},{"issue":"3","key":"7897_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1210\/jcem-69-3-577","volume":"69","author":"R Azziz","year":"1989","unstructured":"Azziz R, Zacur HA (1989) 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. J Clin Endocrinol Metab 69(3):577\u2013584","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7897_CR18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1210\/jcem-55-5-817","volume":"55","author":"B Kohn","year":"1982","unstructured":"Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, Levy D et al (1982) Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 55(5):817\u2013827","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7897_CR19","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1210\/jc.2008-1582","volume":"94","author":"M Bidet","year":"2009","unstructured":"Bidet M, Bellanne-Chantelot C, Galand-Portier MB, Tardy V, Billaud L, Laborde K et al (2009) Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 94(5):1570\u20131578","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"7897_CR20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.4158\/EP151085.RA","volume":"22","author":"H Falhammar","year":"2016","unstructured":"Falhammar H, Torpy DJ (2016) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as adrenal incidentaloma: a systematic review and meta-analysis. Endocr Pract 22(6):736\u2013752","journal-title":"Endocr Pract"},{"issue":"4","key":"7897_CR21","first-page":"810","volume":"78","author":"R Azziz","year":"1994","unstructured":"Azziz R, Dewailly D, Owerbach D (1994) Clinical review 56: nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78(4):810\u2013815","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7897_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF03348395","volume":"7","author":"E Carmina","year":"1984","unstructured":"Carmina E, Gagliano AM, Rosato F, Maggiore M, Janni A (1984) The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency). J Endocrinol Invest 7(2):89\u201392","journal-title":"J Endocrinol Invest"},{"key":"7897_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1017\/S0962279900001162","volume":"4","author":"E Carmina","year":"1995","unstructured":"Carmina E (1995) Pathogenesis and treatment of hirsutism in late-onset congenital adrenal hyperplasia. Reprod Med Rev. 4:179\u2013187","journal-title":"Reprod Med Rev."},{"issue":"2","key":"7897_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.7326\/0003-4819-96-2-143","volume":"96","author":"GP Chrousos","year":"1982","unstructured":"Chrousos GP, Loriaux DL, Mann DL, Cutler GB Jr (1982) Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. Ann Intern Med 96(2):143\u2013148","journal-title":"Ann Intern Med"},{"issue":"4","key":"7897_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0015-0282(16)54592-0","volume":"56","author":"JH Levin","year":"1991","unstructured":"Levin JH, Carmina E, Lobo RA (1991) Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia? Fertil Steril 56(4):635\u2013640","journal-title":"Fertil Steril"},{"issue":"2","key":"7897_CR26","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.fertnstert.2009.06.025","volume":"94","author":"M Pall","year":"2010","unstructured":"Pall M, Azziz R, Beires J, Pignatelli D (2010) The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril 94(2):684\u2013689","journal-title":"Fertil Steril"},{"key":"7897_CR27","doi-asserted-by":"publisher","first-page":"625105","DOI":"10.1186\/1687-9856-2010-625105","volume":"2010","author":"SF Witchel","year":"2010","unstructured":"Witchel SF, Azziz R (2010) Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010:625105","journal-title":"Int J Pediatr Endocrinol"},{"issue":"11","key":"7897_CR28","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1210\/jc.2010-0917","volume":"95","author":"W Arlt","year":"2010","unstructured":"Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S et al (2010) Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 95(11):5110\u20135121","journal-title":"J Clin Endocrinol Metab"},{"key":"7897_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000341673","volume":"40","author":"S Livadas","year":"2013","unstructured":"Livadas S, Diamanti-Kandarakis E (2013) Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach. Front Horm Res 40:1\u201321","journal-title":"Front Horm Res"},{"issue":"2","key":"7897_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1210\/jcem-63-2-418","volume":"63","author":"D Dewailly","year":"1986","unstructured":"Dewailly D, Vantyghem-Haudiquet MC, Sainsard C, Buvat J, Cappoen JP, Ardaens K et al (1986) Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. J Clin Endocrinol Metab 63(2):418\u2013423","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7897_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1055\/s-2003-43307","volume":"21","author":"C Moran","year":"2003","unstructured":"Moran C, Azziz R (2003) 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender. Semin Reprod Med 21(3):295\u2013300","journal-title":"Semin Reprod Med"},{"issue":"2","key":"7897_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2003-031122","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC et al (2004) Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89(2):453\u2013462","journal-title":"J Clin Endocrinol Metab"},{"issue":"6543","key":"7897_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","volume":"293","author":"J Adams","year":"1986","unstructured":"Adams J, Polson DW, Franks S (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 293(6543):355\u2013359","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"5","key":"7897_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/eje.0.1490439","volume":"149","author":"E Cela","year":"2003","unstructured":"Cela E, Robertson C, Rush K, Kousta E, White DM, Wilson H et al (2003) Prevalence of polycystic ovaries in women with androgenic alopecia. Eur J Endocrinol 149(5):439\u2013442","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"7897_CR35","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","volume":"10","author":"AH Balen","year":"1995","unstructured":"Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C et al (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10(8):2107\u20132111","journal-title":"Hum Reprod"},{"issue":"3","key":"7897_CR36","first-page":"635","volume":"74","author":"S Feldman","year":"1992","unstructured":"Feldman S, Billaud L, Thalabard JC, Raux-Demay MC, Mowszowicz I, Kuttenn F et al (1992) Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 74(3):635\u2013639","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"7897_CR37","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1067\/mob.2000.108020","volume":"183","author":"C Moran","year":"2000","unstructured":"Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibanez L et al (2000) 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 183(6):1468\u20131474","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"7897_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1677\/joe.0.1810355","volume":"181","author":"SN Kelly","year":"2004","unstructured":"Kelly SN, McKenna TJ, Young LS (2004) Modulation of steroidogenic enzymes by orphan nuclear transcriptional regulation may control diverse production of cortisol and androgens in the human adrenal. J Endocrinol 181(2):355\u2013365","journal-title":"J Endocrinol"},{"issue":"5","key":"7897_CR39","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/humrep\/dex044","volume":"32","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, Lee I, Sammel MD, Dokras A (2017) High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 32(5):1075\u20131091","journal-title":"Hum Reprod"},{"issue":"1","key":"7897_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jsxm.2015.11.002","volume":"13","author":"R Krysiak","year":"2016","unstructured":"Krysiak R, Drosdzol-Cop A, Skrzypulec-Plinta V, Okopien B (2016) Sexual function and depressive symptoms in young women with nonclassic congenital adrenal hyperplasia. J Sex Med 13(1):34\u201339","journal-title":"J Sex Med"},{"issue":"7","key":"7897_CR41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jamadermatol.2016.0358","volume":"152","author":"L Pasch","year":"2016","unstructured":"Pasch L, He SY, Huddleston H, Cedars MI, Beshay A, Zane LT et al (2016) Clinician vs self-ratings of hirsutism in patients with polycystic ovarian syndrome: associations with quality of life and depression. JAMA Dermatol 152(7):783\u2013788","journal-title":"JAMA Dermatol"},{"issue":"5","key":"7897_CR42","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/humupd\/dmx014","volume":"23","author":"E Carmina","year":"2017","unstructured":"Carmina E, Dewailly D, Escobar-Morreale HF, Kelestimur F, Moran C, Oberfield S et al (2017) Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum Reprod Update 23(5):580\u2013599","journal-title":"Hum Reprod Update"},{"issue":"5","key":"7897_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0015-0282(99)00383-0","volume":"72","author":"R Azziz","year":"1999","unstructured":"Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots LR (1999) Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 72(5):915\u2013925","journal-title":"Fertil Steril"},{"issue":"6","key":"7897_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101894","volume":"50","author":"S Lie Fong","year":"2021","unstructured":"Lie Fong S, Douma A, Verhaeghe J (2021) Implementing the international evidence-based guideline of assessment and management of polycystic ovary syndrome (PCOS): how to achieve weight loss in overweight and obese women with PCOS? J Gynecol Obstet Hum Reprod 50(6):101894","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"2","key":"7897_CR45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/biomedicines12020349","volume":"12","author":"A Gudovi\u0107","year":"2024","unstructured":"Gudovi\u0107 A, Bukumiri\u0107 Z, Milincic M, Pupovac M, Andji\u0107 M, Ivanovic K et al (2024) The comparative effects of myo-inositol and metformin therapy on the clinical and biochemical parameters of women of normal weight suffering from polycystic ovary syndrome. Biomedicines 12(2):349","journal-title":"Biomedicines"},{"issue":"1","key":"7897_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cen.14913","volume":"99","author":"M Forslund","year":"2023","unstructured":"Forslund M, Melin J, Alesi S, Piltonen T, Romualdi D, Tay CT et al (2023) Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review. Clin Endocrinol 99(1):79\u201391","journal-title":"Clin Endocrinol"},{"issue":"6","key":"7897_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41574-022-00655-w","volume":"18","author":"A Mallappa","year":"2022","unstructured":"Mallappa A, Merke DP (2022) Management challenges and therapeutic advances in congenital adrenal hyperplasia. Nat Rev Endocrinol 18(6):337\u2013352","journal-title":"Nat Rev Endocrinol"},{"key":"7897_CR48","doi-asserted-by":"publisher","first-page":"1064024","DOI":"10.3389\/fendo.2022.1064024","volume":"13","author":"BPH Adriaansen","year":"2022","unstructured":"Adriaansen BPH, Schr\u00f6der MAM, Span PN, Sweep F, van Herwaarden AE, Claahsen-van der Grinten HL (2022) Challenges in treatment of patients with non-classic congenital adrenal hyperplasia. Front Endocrinol (Lausanne) 13:1064024","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07897-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07897-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07897-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:16:39Z","timestamp":1739358999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07897-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["7897"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07897-1","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"V.U., E.L., G.F. are employees of Lo.Li Pharma s.r.l. The other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}